4-(4-(4-(4-(((2S,4R)-2-((1H-tetrazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)-3-fluorophenyl)-2-(sec-butyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

ID: ALA4640665

Chembl Id: CHEMBL4640665

PubChem CID: 137469580

Max Phase: Preclinical

Molecular Formula: C34H36Cl2FN9O4

Molecular Weight: 724.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cnnn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)c(F)c2)c1=O

Standard InChI:  InChI=1S/C34H36Cl2FN9O4/c1-3-23(2)46-33(47)45(22-39-46)26-7-11-32(31(37)17-26)43-14-12-42(13-15-43)25-5-8-27(9-6-25)48-18-28-19-49-34(50-28,20-44-21-38-40-41-44)29-10-4-24(35)16-30(29)36/h4-11,16-17,21-23,28H,3,12-15,18-20H2,1-2H3/t23?,28-,34-/m1/s1

Standard InChI Key:  QMZYKRSGHWAYAR-XTJXQDSVSA-N

Alternative Forms

  1. Parent:

    ALA4640665

    ---

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPC1 Tchem Niemann-Pick C1 protein (18985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 724.62Molecular Weight (Monoisotopic): 723.2251AlogP: 5.11#Rotatable Bonds: 11
Polar Surface Area: 117.59Molecular Species: NEUTRALHBA: 13HBD:
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): #RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 3.78CX LogP: 7.09CX LogD: 7.09
Aromatic Rings: 5Heavy Atoms: 50QED Weighted: 0.18Np Likeness Score: -1.07

References

1. Li Y, Pasunooti KK, Peng H, Li RJ, Shi WQ, Liu W, Cheng Z, Head SA, Liu JO..  (2020)  Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors.,  11  (6): [PMID:32550989] [10.1021/acsmedchemlett.9b00438]

Source